Sekundäre Hyperurikämie und Gicht

  • W. Gröbner

Zusammenfassung

Thannhauser unterschied 1929 als erster zwischen primärer und sekundärer Gicht, wobei er die sekundäre Gicht als Folge einer „schweren, anatomisch sichtbaren Nierenerkrankung“ ansah. Diese Definition Thannhausers wurde zunächst nicht zur Kenntnis genommen oder vergessen. Die endgültige Einführung des Begriffs „sekundäre Gicht“ erfolgte durch Gutman (1953), der diese Bezeichnung allerdings in erster Linie für die Gicht bei Blutkrankheiten mit vermehrtem Zellumsatz verwen dete. Zöllner (1960) hat die Definitionen von Thannhauser und Gutman erstmals zusammengefaßt und darauf hingewiesen, daß sekundäre Hyperurikämie und sekundäre Gicht nicht nur bei Krankheiten des Bluts und der Nieren, sondern auch bei anderen Krankheiten (z. B. Glykogenspeicherkrankheit Typ I) vorkommen können.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aronoff A (1960) Acute gouty arthritis precipitated by chlorothiazide. N Engl J Med 262: 767.PubMedCrossRefGoogle Scholar
  2. Babucke G, Sagebiel L, Mertz DP (1976) Hyperurikämie bei Parkinson-Syndrom — zufällig oder wahrscheinlich? Münch Med Wochenschr 118: 1489.Google Scholar
  3. Bartelheimer HK, Kurme A, Altenähr E (1969) Gicht als Ursache akuten Nierenversagens bei einem 10jährigen Kind mit Reticulosarkomatose. Monatsschr Kinderheilk 117: 112.Google Scholar
  4. Buchanan WW, Klinenberg JR, Seegmiller JE (1965) The inflammatory response to injected microcrystalline monosodium urate in normal, hyperuricemic, gouty and uremic subjects. Arthritis Rheum 8: 361.PubMedCrossRefGoogle Scholar
  5. Christensson T (1977) Serum urate in subjects with hypercalcaemic hyperparathyroidism. Clin Chim Acta 80: 529.PubMedCrossRefGoogle Scholar
  6. Common AF, Wadsworth RJ (1968) An evaluation of serum uric acid estimations in toxemia of pregnancy. Aust NZ J Obstet Gynaecol 8: 197.CrossRefGoogle Scholar
  7. Damon A, Holub DA (1958) Host factors in polycythemia vera. Ann Intern Med 49: 43.PubMedGoogle Scholar
  8. Deitrick JE (1940) The association of congenital hemolytic icterus and gout. Int Clin 3: 264.Google Scholar
  9. Dent CE (1962) Some problems of hyperparathyroidism. Br Med J 2: 1419.PubMedCrossRefGoogle Scholar
  10. Einarson TR, Turchet EN, Goldstein JE, MacNay KR (1985) Gout — like arthritis after cimetidine and ranitidine. Drug Intell Clin Pharm 19: 201.PubMedGoogle Scholar
  11. Eisen AZ, Seegmiller JE (1961) Uric acid metabolism in psoriasis. J Clin Invest 40: 1486.PubMedCrossRefGoogle Scholar
  12. Emmerson BT (1963) Chronic lead nephropathy. The diagnostic use of calcium EDTA and the association with gout. Aust Ann Med 12: 310.PubMedGoogle Scholar
  13. Emmerson BT (1974) Effect of oral fructose on urate production. Ann Rheum Dis 33: 276.PubMedCrossRefGoogle Scholar
  14. Engelhardt R, von der Thann M, Löhr GW (1980) Die Prävention der akuten Uratnephropathie. Med Welt 31: 1450.PubMedGoogle Scholar
  15. Faller J, Fox JH (1982) Ethanol — induced hyperuricemia. Evidence for increased production by activation of adenine nucleotide turnover. N Engl J Med 307: 1598.PubMedCrossRefGoogle Scholar
  16. Förster H, Mehnert H, Alhong J (1967) Anstieg der Serumharnsäure nach Verabreichung von Fructose. Klin Wochenschr 45: 436.PubMedCrossRefGoogle Scholar
  17. Förster H, Meyer E, Ziege M (1970) Erhöhung von Serumharnsäure und Serumbilirubin nach hochdosierten Infusionen von Sorbit, Xylit und Fruktose. Klin Wochenschr 48: 878.PubMedCrossRefGoogle Scholar
  18. Förster H, Ziege M (1971) Anstieg der Serumharnsäurekonzentration nach oraler Zufuhr von Fruktose, Sorbit und Xylit. Z Ernährungswiss 10: 394.PubMedCrossRefGoogle Scholar
  19. Fox JH, Kelley WN (1972) Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism 21: 713.PubMedCrossRefGoogle Scholar
  20. Fuller RW, Luce MW, Mertz ET (1962) Serum uric acid in mongolism. Science 137: 868.PubMedCrossRefGoogle Scholar
  21. Gershon SL, Fox IH (1974) Pharmacologic effects of nicotinic acid on human purine metabolism. J Lab Clin Med 84: 179.PubMedGoogle Scholar
  22. Goldfinger S, Klinenberg JR, Seegmiller JE (1965) Renal retention of uric acid induced by infusion of betahydroxybutyrate and acetoacetate. N Engl J Med 272: 351.PubMedCrossRefGoogle Scholar
  23. Goldstein RA, Becker KD, Israel HL (1974) Urate metabolism in sarcoidosis. Arch Intern Med 133: 379.PubMedCrossRefGoogle Scholar
  24. Gröbner W, Zöllner N (1971) unveröffentlicht.Google Scholar
  25. Grunst J, Dietze G, Wicklmayer M (1973) Einfluß von Äthanol auf den Purinkatabolismus der menschlichen Leber. Verh Dtsch Ges Inn Med 79: 914.PubMedGoogle Scholar
  26. Grunst J, Dietze G, Wicklmayr M (1977) Effect of ethanol on uric acid production of human liver. Nutr Metab 21(Suppl 1): 138.PubMedGoogle Scholar
  27. Gutman AB (1953) Primary and secondary gout. Ann Intern Med 39: 1062.PubMedGoogle Scholar
  28. Hamilton LD (1956) Nucleic acid turnover studies in human leukaemic cells and the function of lymphocytes. Nature 178: 597.PubMedCrossRefGoogle Scholar
  29. Heilmeyer L, Begemann H (1951) (Hrsg) Blut und Blutkrankheiten. Handbuch der Inneren Medizin, 4. Aufl, Bd II. Springer, Berlin Göttingen Heidelberg.Google Scholar
  30. Heuckenkamp PU, Zöllner N (1971) Fructose-induced hyperuricemia. Lancet I: 808.CrossRefGoogle Scholar
  31. Heuckenkamp PU, Zöllner N (1975) Comparison and evaluation of utilisation of parenteral administered carbohydrates. Nutr Metab 18: 209.PubMedCrossRefGoogle Scholar
  32. Hollander W, Wilkins RW (1966) The pharmacology and clinical use of rauwolfia, hydralazine, thiazides and aldosterone antagonists in arterial hypertension. Prog Cardiovasc Dis 8: 291.PubMedCrossRefGoogle Scholar
  33. Holzmann H, Morsches B, Krapp R (1970) Über Stoffwechselbeziehungen zwischen Psoriasis vulgaris und sekundärer Gicht. Klin Wochenschr 48: 1461.PubMedCrossRefGoogle Scholar
  34. Honda H, Gindin RA (1972) Gout while receiving levodopa for parkinsonism. J Am Med Assoc 219: 55.CrossRefGoogle Scholar
  35. Howell RR (1972) The glycogen storage diseases. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) Metabolic basis of inherited disease. McGraw Hill, New York, p 149.Google Scholar
  36. Kelley WN, Goldfinger SE, Hardy HL (1969) Hyperuricemia in chronic beryllium disease. Ann Intern Med 70: 977.PubMedGoogle Scholar
  37. Knochel JP, Dotin LN, Hamburger RJ (1974) Heat, stress, exercise and muscle injury: Effects on urate metabolism and renal function. Ann Intern Med 81: 321.PubMedGoogle Scholar
  38. König E, Zöllner N (1962) Sekundäre Gicht bei Osteomyelosklerose und bei Polycythaemia vera. Med Klinik 57: 1741.Google Scholar
  39. Kolb FO, DeLalla OF, Gofmann JW (1955) The hyperlipidemias in disorders of carbohydrate metabolism. Serial lipoprotein studies in diabetic acidosis with xanthomatosis and in glycogen storage disease. Metabolism 4: 310.PubMedGoogle Scholar
  40. Krakoff IH, Balis ME (1964) Abnormalities of purine metabolism in human leukemia. Ann NY Acad Sci 113: 1043.PubMedCrossRefGoogle Scholar
  41. Lambie CJ (1940) Study of juvenile gout in patients suffering from chronic erythronoclastic anemia of obscure origin, together with observations upon the physical state of uric acid in the blood and effects of splenectomy. Med J Aust 1: 535.Google Scholar
  42. Leschke E (1922) Hemolytic icterus and gout. Med Klin 18: 896.Google Scholar
  43. Lieber ChS (1965) Hyperuricemia induced by alcohol. Arthritis Rheum 8: 786.PubMedCrossRefGoogle Scholar
  44. Lin HJ, Rocher LL, McQuillan MA, Schmaltz St, Palella TD, Fox JH (1989) Cyclosporine-induced hyperuricemia and gout. N Engl J Med 321: 287.PubMedCrossRefGoogle Scholar
  45. Lynch EC (1962) Uric acid metabolism in proliferative diseases of the marrow. Arch Intern Med 109: 639.PubMedCrossRefGoogle Scholar
  46. MacLachlan MJ, Rodnan GP (1967) Effect of food, fast and alcohol on serum uric acid and acute attacks of gout. Am J Med 42: 38.PubMedCrossRefGoogle Scholar
  47. Meyer WJ, Gill JR Jr, Bartter FC (1975) Gout as a complication of Bartter’s syndrome. A possible role for alkalosis in the decreased clearance of uric acid. Ann Intern Med 83: 56.PubMedGoogle Scholar
  48. Naimark A, Fyles TW (1960) Gout as a complication of chlorothiazide therapy. Can Med Assoc J 83: 819.PubMedGoogle Scholar
  49. Narins RG, Weisberg JS, Myers AR (1974) Effects of carbohydrates on uric acid metabolism. Metabolism 23: 455.PubMedCrossRefGoogle Scholar
  50. Neubaur J, Wilms B, Söling HD, Creutzfeld W (1969) Gicht als Komplikation der Glykogenspeicherkrankheit beim Erwachsenen. Arch Klin Med 216: 148.PubMedGoogle Scholar
  51. Nichols J, Miller AT, Hiatt EP (1951) Influence of muscular exercise on uric acid excretion in man. J Appl Physiol 3: 501.PubMedGoogle Scholar
  52. Oliva PB (1970) Lactic acidosis. Am J Med 48: 209.PubMedCrossRefGoogle Scholar
  53. Owen TK, Roberts JC (1937) Acholuric jaundice and gout. Br Med J 2: 661.Google Scholar
  54. Padova J, Bendersky G (1962) Hyperuricemia in diabetic ketoacidosis. N Engl J Med 267: 530.PubMedCrossRefGoogle Scholar
  55. Pant SS, Moser HW, Krane SM (1968) Hyperuricemia in Down’s Syndrome. J Clin Endocrinol Metab 28: 472.PubMedCrossRefGoogle Scholar
  56. Parsons WB (1961) Studies of nicotinic acid use in hypercholesterolemia. Arch Intern Med 107: 653.PubMedCrossRefGoogle Scholar
  57. Perheentupa J, Raivio K (1967) Fructose-induced hyperuricemia. Lancet 2: 528.PubMedCrossRefGoogle Scholar
  58. Pochedly C (1974) Hyperuricemia in leukemia and lymphoma. Postgrad Med 55: 93.PubMedGoogle Scholar
  59. Postlethwaite AE, Bartel AG, Kelley WN (1972) Hyperuricemia due to ethambutol. N Engl J Med 286: 761.PubMedCrossRefGoogle Scholar
  60. Richards P (1979) Drug induced diseases; Drug induced metabolic disease. Br Med J I: 1128.CrossRefGoogle Scholar
  61. Richet G, Mignon F, Ardaillon R (1965) Goutte secondaire de nephropathies chroniques. Presse Med 73: 633.PubMedGoogle Scholar
  62. Rieselbach RE, Steele TH (1974) Influence of the kidney upon urate homeostasis in health and disease. Am J Med 56: 665.PubMedCrossRefGoogle Scholar
  63. Sarre H, Mertz DP (1965) Sekundäre Gicht bei Niereninsuffizienz. Klin Wochenschr 43: 1134.PubMedCrossRefGoogle Scholar
  64. Scott JT, Dixon ASt, Bywaters EG (1964) Association of hyperuricemia and gout with hyperparathyroidism. Br Med J 5390: 1070.CrossRefGoogle Scholar
  65. Sears WG (1933) The occurrence of gout during treatment of pernicious anemia. Lancet 1: 24.CrossRefGoogle Scholar
  66. Shelp WD, Steele TH, Rieselbach RE (1969) Comparison of urinary phosphate, urate and magnesium excretion following parathyroid hormone administration to normal man. Metabolism 18: 63.PubMedCrossRefGoogle Scholar
  67. Sorensen LB (1960) The elimination of uric acid in man studied by means of 14C-labeled uric acid. Scand J Clin Lab Invest 12(Suppl 54): 1.Google Scholar
  68. Sorensen LB (1980) Gout secondary to chronic renal disease: studies on urate metabolism. Ann Rheum Dis 39: 424.PubMedCrossRefGoogle Scholar
  69. Suki WN, Hull AR, Rector FC, Seidin DW (1967) Mechanism of the effect of thiazide diuretics on calcium and uric acid. J Clin Invest 46: 1121.Google Scholar
  70. Sutton JR, Toews CJ, Ward GR, Fox IH (1980) Purine metabolism during strenuous muscular exercise in man. Metabolism 29: 254.PubMedCrossRefGoogle Scholar
  71. Schwenk HU, Schneider U (1982) Lebensbedrohliche Hyperurikämie bei zytostatischer Leukämie-Therapie. Fortschr Med 100: 454.PubMedGoogle Scholar
  72. Steele TH, Rieselbach RE (1967) The contribution of residual nephrons within the chronically diseased kidney to urate homeostasis in man. Am J Med 43: 876.PubMedCrossRefGoogle Scholar
  73. Steele TH, Oppenheimer S (1969) Factors affecting urate excretion following diuretic administration in man. Am J Med 47: 564.PubMedCrossRefGoogle Scholar
  74. Stroebel CF, Law WM (1956) Polycythemia vera. Med Clin North Am 40: 1045.PubMedGoogle Scholar
  75. Talbott JH (1959) Gout and blood dyscrasias. Medicine 38: 173.PubMedGoogle Scholar
  76. Thannhauser SJ (1929) Lehrbuch des Stoffwechsels und der Stoffwechselkrankheiten. Bergmann, München.CrossRefGoogle Scholar
  77. Tinney WS, Polley HF, Hall BE, Griffin HZ (1945) Polycythemia vera and gout: report of eight cases. Proc Mayo Clin 20: 49.Google Scholar
  78. Videbaek A (1950) Polycythaemia vera: course and prognosis. Acta Med Scand 138: 179.PubMedCrossRefGoogle Scholar
  79. Vining CW, Thompson JG (1934) Gout and aleukemic leukemia in a boy aged five. Arch Dis Child 9: 277.PubMedCrossRefGoogle Scholar
  80. Wasserman LR (1954) Polycythemia vera: Its course and treatment: Relation to myeloid metaplasia and leukemia. Bull NY Acad Med 30: 343.Google Scholar
  81. Weisberger AS, Persky L (1953) Renal calculi and uremia as complications of lymphoma. Am J Med Sci 225: 669.PubMedCrossRefGoogle Scholar
  82. Woolliscroft JO, Colfer H, Fox IH (1982) Hyperuricemia in acute illness: a poor prognostic sign. Am J Med 72: 58.PubMedCrossRefGoogle Scholar
  83. Wyngaarden JB, Kelley WN (1976) Gout and hyperuricemia. Grune & Stratton, New York San Francisco London.Google Scholar
  84. Yü TF, Sirota JH, Berger L, Halpern M, Gutman AB (1957) Effect of sodium lactate infusion on urate clearance in man. Proc Soc Exp Biol Med 96: 809.PubMedGoogle Scholar
  85. Yü TF (1965) Secondary gout associated with myeloproliferative diseases. Arthritis Rheum 8: 765.PubMedCrossRefGoogle Scholar
  86. Zöllner N (1960) Moderne Gichtprobleme. Ätiologie, Pathogenese, Klinik. Ergeb Inn Med Kinderheilkd 14: 321.Google Scholar
  87. Zöllner N (1976) Sekundäre Hyperurikämie und sekundäre Gicht. In: Zöllner N, Gröbner W (Hrsg) Handbuch der Inneren Medizin, Bd. VII/3 Springer, Berlin Heidelberg New York, S 164.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • W. Gröbner

There are no affiliations available

Personalised recommendations